norethindrone acetate has been researched along with Condition, Preneoplastic in 2 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of breast cancer was also significantly lower in the estrogen-progestogen users (66." | 1.27 | Use of progestogen therapy. ( Gambrell, RD, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gambrell, RD | 2 |
| Massey, FM | 1 |
| Castaneda, TA | 1 |
| Ugenas, AJ | 1 |
| Ricci, CA | 1 |
| Wright, JM | 1 |
2 other studies available for norethindrone acetate and Condition, Preneoplastic
| Article | Year |
|---|---|
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medro | 1980 |
Use of progestogen therapy.
Topics: Breast Neoplasms; Cholesterol, HDL; Drug Therapy, Combination; Estrogens; Female; Humans; Menopause; | 1987 |